doi: 10.1080/10245330701448529.
Fixed dose prothrombin complex concentrate for the reversal of oral anticoagulation therapy
Affiliations
- PMID: 17852462
- DOI: 10.1080/10245330701448529
Item in Clipboard
Fixed dose prothrombin complex concentrate for the reversal of oral anticoagulation therapy
Hematology.
2007 Oct.
Free article
Abstract
Warfarin reversal is frequently required in day to day haematology practice. Prothrombin complex concentrates (PCC) have replaced fresh frozen plasma as the agent of choice in warfarin reversal due to its safety profile. Ideal dose of PCC is still not known and many centres have local guidelines on using the product. We have successfully used PCC (Beriplex) at a fixed dose in our hospital, but we still need randomised control trials to identify the ideal dose of PCC which can result in rapid reversal of warfarin with minimum risk of thrombosis.
Similar articles
-
Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy.Pharmacotherapy. 2014 Mar;34(3):260-4. doi: 10.1002/phar.1384. Epub 2013 Dec 12. Pharmacotherapy. 2014. PMID: 24338807
-
Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal.Ann Hematol. 2010 Mar;89(3):309-16. doi: 10.1007/s00277-009-0830-7. Epub 2009 Sep 29. Ann Hematol. 2010. PMID: 19787352 Clinical Trial.
-
Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.Clin Neurol Neurosurg. 2013 Jun;115(6):770-4. doi: 10.1016/j.clineuro.2012.07.006. Epub 2012 Jul 24. Clin Neurol Neurosurg. 2013. PMID: 22835715
-
Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature.Neurocrit Care. 2010 Jun;12(3):403-13. doi: 10.1007/s12028-009-9310-0. Neurocrit Care. 2010. PMID: 19967567 Review.
-
Prothrombin complex concentrates in emergency bleeding disorders.Am J Hematol. 2012 Sep;87(9):898-902. doi: 10.1002/ajh.23254. Epub 2012 May 31. Am J Hematol. 2012. PMID: 22648513 Review.
Cited by
-
Activated prothrombin complex concentrate factor VIII inhibitor bypassing activity (FEIBA) for the reversal of warfarin-induced coagulopathy.Int J Emerg Med. 2009 Nov 26;2(4):217-25. doi: 10.1007/s12245-009-0125-8. Int J Emerg Med. 2009. PMID: 20436891 Free PMC article.
-
An unexpected case of coumarin poisoning with coumatetralyl.BMJ Case Rep. 2011 Apr 13;2011:bcr0520102992. doi: 10.1136/bcr.05.2010.2992. BMJ Case Rep. 2011. PMID: 22701001 Free PMC article.
-
Emergency reversal of antithrombotic treatment.Intern Emerg Med. 2009 Apr;4(2):137-45. doi: 10.1007/s11739-008-0201-8. Epub 2008 Nov 12. Intern Emerg Med. 2009. PMID: 19002653
-
Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital.Crit Care. 2008;12(4):R105. doi: 10.1186/cc6987. Epub 2008 Aug 15. Crit Care. 2008. PMID: 18706082 Free PMC article.
-
Low-dose compared to manufacturer-recommended dose four-factor prothrombin complex concentrate for acute warfarin reversal.J Thromb Thrombolysis. 2019 Feb;47(2):263-271. doi: 10.1007/s11239-018-1768-1. J Thromb Thrombolysis. 2019. PMID: 30443817
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
